Efficacy and Mechanism of Action of 9-cis UAB30, a Novel Rexinoid Analog, in Human Cutaneous T-Cell Lymphoma Cell Lines

Grant

Date/time Interval

  • July 1, 2011 - July 31, 2012
  • Awarded By

    Total Award Amount

  • 10000.00
  • Direct Costs

  • 10000.00
  • Sponsor Award Id

  • Contributor

  • Chang Ph.D., Pi-Ling   Principal Investigator